SENSEX NIFTY

Dr Reddys Laboratories

Dec 05, 2016 at 11:52 | Source: PTI
In a BSE filing, Dr Reddy's Laboratories Ltd said, "It has launched nystatin and triamcinolone acetonide cream USP, in the United States market, approved by the US Food and Drug Administration (USFDA)."
Dec 05, 2016 at 11:14 | Source: CNBC-TV18
Ashwani Gujral, Fund Manager at ashwanigujral.com recommends buying Adani Ports and Tata Elxsi and advises selling Tata Steel.
Dec 05, 2016 at 11:14 | Source: Moneycontrol.com
Dr Reddy's Laboratories has launched Nystatin and Triamcinolone Acetonide Cream, USP in the US market, approved by USFDA.
Dec 05, 2016 at 09:15 | Source: Moneycontrol.com
HDFC is down 4 percent while Dr Reddy's Labs, Asian Paints, HDFC Bank and Wipro are losers in the Sensex while Lupin, M&M, Tata Motors, Bajaj Auto and Hero MotoCorp are gainers.
Dec 03, 2016 at 10:13 | Source: Moneycontrol.com
In the banking space, ICICI Bank was up 0.1 percent at USD 7.68 and HDFC Bank was down 0.87 percent at USD 63.03.
Dec 02, 2016 at 13:00 | Source: Moneycontrol.com
Banks, FMCG and oil stocks are dragging indices. Coal India, Sun Pharma, Reliance and Cipla are top gainers while Tata Motors, Asian Paints, Dr Reddy's Labs, ITC and HDFC are losers in the Sensex.
Dec 02, 2016 at 11:01 | Source: CNBC-TV18
Mitesh Thacker of miteshthacker.com is of the view that one can buy Infosys above Rs 985 and sell DCB Bank.
Dec 02, 2016 at 11:00 | Source: Moneycontrol.com
Coal India, ONGC, Reliance, GAIL and Bharti Airtel are top gainers while HDFC, Dr Reddy's Labs, ITC, HUL and TCS are losers in the Sensex.
Dec 02, 2016 at 09:15 | Source: Moneycontrol.com
Wipro, Coal India and ONGC are top gainers while HDFC, Dr Reddy's Labs, Bharti, GAIL and Infosys are losers in the Sensex.
Dec 02, 2016 at 08:23 | Source: Moneycontrol.com
Nifty has support at 8140 and resistance at 8250 while Bank Nifty has support at 18250 and resistance at 18750, says Prakash Gaba of prakashgaba.com.
Messages on Dr Reddys Laboratories »

Wire News

Platinum Member

670 Followers

News Now  

Dr Reddy's Laboratories Ltd today announced the launch of anti-fungal ointment nystatin and triamcinolone acetonide in the US market.

about 2 hrs 19 min 39 sec ago

BSE/NSE Announcer

Platinum Member

19411 Followers

Dr Reddys Labs  

Dr. Reddys Laboratories Limited has informed the Exchange regarding allotment of 15850 Equity Shares under ESOP

about 2 hrs 23 min 25 sec ago

BSE/NSE Announcer

Platinum Member

19411 Followers

Dr Reddys Labs  

Dr Reddy's Laboratories has launched Nystatin and Triamcinolone Acetonide Cream, USP in the US market, approved by USFDA.

about 2 hrs 57 min 13 sec ago

BSE/NSE Announcer

Platinum Member

19411 Followers

Dr Reddys Labs  

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated December 05, 2016, titled "Dr. Reddys Laboratories announces the launch of Nystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market".

about 2 hrs 57 min 14 sec ago

BSE/NSE Announcer

Platinum Member

19411 Followers

Dr Reddys Labs  

Dr. Reddys Laboratories Limited has informed the Exchange regarding a press release dated December 05, 2016, titled "Dr. Reddys Laboratories announces the launch ofNystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market".

about 2 hrs 58 min 14 sec ago

Forum Messenger

Platinum Member

376151 Followers

Dr Reddys Labs  

Is Dr Reddys Laboratories looking good for medium term?

1.32 PM Nov 29th

BSE/NSE Announcer

Platinum Member

19411 Followers

Dr Reddys Labs  

Dr Reddys Laboratories Ltd has informed BSE that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company vide a circular resolution passed on November 15, 2016, has granted 496 stock options, exercisable at par value of Rs. 5/- under "Dr. Reddys Employees Stock

12.10 PM Nov 16th

Wire News

Platinum Member

670 Followers

News Now  

Dr Reddy's Laboratories has launched raloxifene hydrochloride tablets in 60 mg, a therapeutic equivalent generic version of Evista tablets, in the United States market.

5.08 PM Nov 11th

BSE/NSE Announcer

Platinum Member

19411 Followers

Dr Reddys Labs  

Dr Reddy's Laboratories has launched Raloxifene Hydrochloride tablets in 60 mg in the US market.

2.57 PM Nov 11th

BSE/NSE Announcer

Platinum Member

19411 Followers

Dr Reddys Labs  

Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated November 11, 2016 titled "Dr. Reddys Laboratories announces the launch of Raloxifene HCI Tablets, USP in the U.S. Market".

2.24 PM Nov 11th

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.